Try our Advanced Search for more refined results
Corporate
-
April 14, 2026
'Women Only Have Tattoos?' Judges Doubt Bias At RTX Unit
Connecticut appellate judges sounded skeptical Tuesday that a female mechanic could support a gender bias claim against RTX Corp.'s Pratt & Whitney division by citing her short stature and tattoos, noting that those characteristics are not gender-specific.
-
April 14, 2026
Red State AGs Fight Bid To Trim Suit Against BlackRock
Republican attorneys general are opposing a bid by BlackRock and State Street to trim a suit accusing the asset managers of driving up coal prices, arguing that the firms' assertion that the suit cannot get past the U.S. Supreme Court's decision on federal antitrust damages claims is incorrect.
-
April 14, 2026
IBM's FCA Deal Creates Unease Over DEI Enforcement Scope
IBM's agreement to pay the Trump administration $17 million to resolve allegations it violated the False Claims Act with policies aimed at increasing the diversity of its workforce continues to raise more questions than answers about what the administration views as illegal diversity, equity and inclusion programs.
-
April 14, 2026
Proxy Co. Sues Ind. AG Over 'Unconstitutional' Disclosure Law
Institutional Shareholder Services Inc. has sued Indiana's attorney general over a law the proxy adviser said violates the First and Fourteenth amendments and imposes onerous disclosure requirements for issuing recommendations that go against the preferred outcome of corporate managers.
-
April 14, 2026
Crypto Co-Founder Alleges $58M Fraud, RICO Scheme
A co-founder of a cryptocurrency data company has accused his former partner and affiliates of violating the Racketeer Influenced and Corrupt Organizations Act through a $58 million fraudulent scheme that he says involved diverting virtual tokens from a company offering to offshore vehicles and attempting to shift the blame with retaliatory litigation.
-
April 14, 2026
Vertex Sues Former Exec To Block Move To Rival
Vertex Pharmaceuticals asked a Massachusetts state court judge to bar a former executive from taking a virtually identical role at competitor Vera Therapeutics, citing a noncompete agreement he allegedly signed.
-
April 14, 2026
Del. Chancery Tosses Jenzabar Suit As Untimely, Defective
The Delaware Chancery Court has dismissed a stockholder lawsuit against educational software company Jenzabar Inc. and its founder, finding the claims were procedurally flawed, too late and, in some respects, premature.
-
April 14, 2026
Meta, Others Can't Look At Internal Data To Probe Jury Pool
A California federal judge on Tuesday granted an uncontested bid by school district plaintiffs to bar Meta and other social media companies from using nonpublic information — including their internal data — to investigate potential jurors for an upcoming bellwether trial in multidistrict litigation over the alleged harms of social media addiction.
-
April 14, 2026
Lead-Plaintiff Fight Comes First In LRN Suit, Chancery Says
The Delaware Chancery Court signaled Tuesday that it will prioritize sorting out who can lead a long-running stockholder suit against LRN Corp.'s leaders before turning to the merits, as the judge pushed the parties toward a structured path forward after years of procedural detours.
-
April 14, 2026
3 Firms Guide TPG's Bet On College Sports Rights Giant
Alternative asset manager TPG said Tuesday it has agreed to acquire Learfield, a leading college sports media and technology company, in a deal steered by three law firms.
-
April 14, 2026
Delaware Eyes Stablecoin Edge With Banking Law Overhaul
Delaware lawmakers and industry attorneys say a pair of proposed bills updating the state's banking laws and creating a regulatory framework for payment stablecoins are aimed at ensuring the state remains a leader as financial services evolve, just as it did decades ago with credit card banking and corporate law.
-
April 14, 2026
Buyers Seek Final Approval Of $4.85M Bayer Benzene Deal
A class of consumers is asking a New Jersey federal court to give final approval of a $4.85 million settlement to resolve claims that Bayer US LLC's antifungal products were contaminated with benzene.
-
April 14, 2026
7th Circ. Orders New Trial For Ex-ComEd CEO, Lobbyist
The Seventh Circuit on Tuesday ordered the release of the former CEO and a former lobbyist of Commonwealth Edison on bond pending a new trial, just hours after hearing arguments on their bids to unwind convictions for allegedly funneling and hiding payments to ex-Illinois House Speaker Michael Madigan's allies.
-
April 14, 2026
Holland & Knight Hires ERISA, Compensation Pro From Katten
Holland & Knight LLP announced on Monday that it had hired a Katten Muchin Rosenman LLP partner who focuses on the Employee Retirement Income Security Act, employee benefits and executive compensation.
-
April 14, 2026
Holtec Suit Alleging Fraud Scheme Can Resume, Court Rules
A New Jersey state court judge has granted Holtec International's bid to lift a stay and amend its suit alleging fraud claims against its former general counsel and others accused of embezzling tens of millions of dollars from the company.
-
April 14, 2026
White & Case Leadership Trio Join Dechert In DC
Dechert LLP has hired the heads of White & Case LLP's practices in trials, sports and gaming, and U.S. government contracts to work in Washington, D.C., with its enforcement and investigations group.
-
April 13, 2026
Disney, WB, Universal's AI Suit Is 'Artificial,' Tech Cos. Say
Chinese artificial intelligence companies have urged a California federal court to throw out allegations from Disney, Warner Bros. Discovery and Universal that their service has been stealing the studios' intellectual property, calling it "ironic" that the case about artificial intelligence is "entirely artificial."
-
April 13, 2026
Oracle Wins TRO Against Ex-Worker Threatening Secrets Sale
A North Carolina federal judge Monday issued a temporary restraining order barring a recently laid-off Oracle sales employee from disclosing trade secrets that the software firm alleges he has threatened to sell to the "highest bidder" unless he receives an "unreasonable" fee.
-
April 13, 2026
Bio Energy Sues Cos. Over Failed Ohio Renewable Gas Plants
Bio Energy has sued SCS Energy and a subcontractor in Ohio federal court in connection with projects replacing two landfill gas processing plants with pipeline-quality renewable natural gas in Youngstown and Lorain that it alleged remain defective due to the "consistent downplay of their botched design and inability to remedy their deficiencies."
-
April 13, 2026
OpenAI State Murder-Suicide Case Doesn't Ax Federal Suit
The estate of a man who it claims was driven by ChatGPT to murder his mother and commit suicide can proceed with its federal suit against OpenAI, a California judge ruled Monday, saying there's "substantial doubt" that a state court case brought by the mother's estate would resolve the federal action's claims.
-
April 13, 2026
Crypto Suit Fails Without Proof Of Partnership, 2nd Circ. Says
An Oregon man has not shown that he is entitled to a share of profits from a purported joint venture in cryptocurrency investment involving a once close friend, the Second Circuit said Monday, affirming a Manhattan federal judge's dismissal of the claims.
-
April 13, 2026
DC Circ. Digs Into FTC Rationale For Media Matters Probe
A D.C. Circuit panel tore into a Federal Trade Commission lawyer on Monday as the agency fought to convince the three judges that a lower court had no right to block it from investigating a left-leaning media watchdog, a probe the group claims is retaliation for publishing anti-Nazi content.
-
April 13, 2026
State Meta Verdicts May Offer Clues For 1st Federal Bellwether
Meta's recent state jury losses in suits over social media's harms to mental health provide clues as to what will happen this summer when a school district's suit against social platforms goes to trial in the first federal bellwether — and down the road in appeals some believe will reach the nation's high court.
-
April 13, 2026
Del. Judge Ends 80K Pre-2026 Zantac Cases
A Delaware state court on Monday dismissed more than 80,000 suits filed before December alleging that Boehringer Ingelheim's discontinued heartburn medication Zantac caused cancer, following a Delaware Supreme Court ruling on admissibility of the plaintiffs' experts.
-
April 13, 2026
Catching Up With Delaware's Chancery Court
The Delaware Chancery Court's docket this past week featured a mix of high-stakes settlements, fast-moving deal litigation, governance disputes and a notable post-trial ruling involving fraud-tainted loans.
Expert Analysis
-
Share Repurchases Leave Cos. Susceptible To Litigation
Because share repurchases bring greater ownership, which typically brings greater voting power, they can have serious implications for corporate control, which can raise questions about the unpaid benefits to some shareholders and lead to securities class actions, says Amit Bubna at Bates White.
-
How The New Tariff Landscape May Unfold
To replace tariffs formerly imposed under the International Emergency Economic Powers Act, the administration will rely on a patchwork of statutes, potentially leading to procedural challenges and a complex tariff landscape with varying levels, durations and applicability, says Joseph Grossman-Trawick at King & Spalding.
-
How DOJ Is Rethinking Corporate Crime Prosecution Tactics
Recent statements from the Justice Department seem to indicate an incremental shift away from relying on collective employee knowledge when prosecuting corporate crime, and from exploring the bounds of case law that has not been a model of clarity, say attorneys at Covington.
-
Del. Justices' Upholding Of SB 21 Gives Cos. Needed Clarity
The Delaware Supreme Court's recent unanimous decision in Rutledge v. Clearway Energy — upholding 2025 corporate law amendments enacted through S.B. 21, which clarified safe harbor protections and key terms — may help stem the DExit movement, whose proponents have claimed unpredictability in Delaware courts, say attorneys at Nelson Mullins.
-
Unique Issues Facing Brand-Compounder Patent Litigation
Recent litigation and potential enforcement action against Hims & Hers Health raise questions about how compounders and branded pharmaceuticals companies would be positioned in patent litigation as compared to generics companies, which would require strategies different from those that would be used in traditional Hatch-Waxman Act litigation, say attorneys at Morgan Lewis.
-
How Banks Can Apply FinCEN Beneficial Ownership Relief
A recent Financial Crimes Enforcement Unit order limiting the circumstances under which banks should identify and verify beneficial owners may allow banks to tailor their approach to verification compliance, but only after reviewing customer due diligence policies and evaluating alignment with their risk profiles, say attorneys at Cleary.
-
Series
Volunteering With Scouts Makes Me A Better Lawyer
Serving as an assistant scoutmaster for my son’s troop reaffirmed several skills and principles crucial to lawyering — from the importance of disconnecting to the value of morality, says Michael Warren at McManis Faulkner.
-
AI Communications May Be Discoverable In Patent Litigation
A New York federal court's recent determination that a defendant's correspondence with an artificial intelligence tool was not protected by attorney-client privilege may have significant ramifications for patent matters, highlighting the risk of AI use in patent prosecution and litigation tasks, say attorneys at Seed IP.
-
Series
Law School's Missed Lessons: In Court, It's About Storytelling
Law school provides doctrine, cases and hypotheticals, but when lawyers step into the courtroom, they must learn the importance of clarity, credibility, memorability and preparation — in other words, how to tell simple, effective stories, say Nicholas Steverson and Danielle Trujillo at Wheeler Trigg, and Lisa DeCaro at Courtroom Performance.
-
How Leveraged Lending Pivot May Alter Bank Risk Oversight
The Federal Deposit Insurance Corp. and Office of the Comptroller of the Currency's recent withdrawal of leveraged lending guidance introduces several principles that may allow banks to better apply enterprisewide risk management programs and potentially create additional competition in the private credit loan market, say attorneys at Mayer Brown.
-
Why SDNY May Be Dusting Off The Financial Kingpin Statute
The Southern District of New York’s recent fraud indictments against executives of bankrupt companies Tricolor and First Brands have seemingly revived the Continuing Financial Crimes Enterprise statute, and if the cases succeed, prosecutors across the country will have ample reason to reach for this long-dormant tool, say attorneys at Lankler Siffert & Wohl.
-
What US Arms Sales Reforms Mean For Defense Industry
A recent executive order with the goal of increasing U.S. arms sales transparency, speed and government-industry collaboration carries both promise and risk for the defense industry as the government seeks to leverage the private sector and use commercial products for defense purposes, say attorneys at Fluet.
-
How Recent Del. Rulings Clarify M&A Deal Fraud Carveouts
Two recent Delaware decisions have provided clarity regarding when a party can or cannot rely on representations made during the course of an M&A transaction, particularly on the scope and enforceability of antireliance provisions, and on representations they knew or should have known were false, says Anthony Boccamazzo at Olshan Frome.
-
Charges Signal Tougher Stance On Execs' Bankruptcy Fraud
The recent criminal charges stemming from the Tricolor and First Brands bankruptcy cases may represent a sea change in the willingness of federal prosecutors to use bankruptcy fraud as a basis to charge corporate officers more frequently alongside traditional statutes such as wire fraud, bank fraud and money laundering, say attorneys at White & Case.
-
A Tale Of 2 Self-Disclosure Policies: How SDNY, DOJ Differ
Though the U.S. Attorney’s Office for the Southern District of New York’s recently announced corporate enforcement and voluntary self-disclosure policy shares many similarities with that of the U.S. Department of Justice, the two programs differ in meaningful ways, including subject matter scope and timeline to declination, say attorneys at Wiley.